Overview
Beizray is approved by the U.S. Food and Drug Administration (FDA) for the treatment of breast cancer. It is indicated as a single agent for locally advanced or metastatic breast cancer after failure of previous…
read moreOverview
Axillary lymph node dissection is the surgical removal of several lymph nodes, usually between five and 30, from the underarm area. It is both a diagnostic procedure performed in order to determine whether breast…
read more